Owen B. Wallace, Chief Scientific Officer at Fulcrum Therapeutics, Inc. (FULC), sold 141 shares at $20.00 ($3K) on 2020-06-30, disclosed to the SEC on 2020-07-01.
Scheduled sale ($3k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FULC | SELL | 2020-05-29 | $9K | — | Filing → |
| FULC | SELL | 2020-05-28 | $8K | — | Filing → |
| FULC | SELL | 2020-02-20 | $122K | — | Filing → |